Related Experiment Video
Updated: Jan 18, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
WTAP regulates DDX3Y mRNA via m6A modification to promote high glucose-induced podocytes injury and diabetic
Guanxi Li1, Huijuan Zeng1, Guojia Ru1
1The Second Department of Nephrology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Abstract:
Diabetic nephropathy (DN) is a major complication of diabetes, imposing substantial socioeconomic and public health challenges. N6-methyladenosine (m6A) modification, a prevalent epigenetic mechanism, influences cellular processes and disease progression. Wilms' tumor 1-associating protein (WTAP), an m6A methyltransferase subunit, was investigated for its role in DN. Bioinformatics identified differentially expressed genes in DN, and a high glucose (HG)-induced podocyte model was established to mimic DN in vitro. Techniques like Western blot, CCK-8, ELISA, flow cytometry, and TUNEL evaluated protein expression, cell viability, inflammation, oxidative stress, and apoptosis. SRAMP predicted m6A sites in DDX3Y mRNA, validated by MeRIP, while xenograft models confirmed in vivo effects. DDX3Y expression was elevated in DN and HG-induced podocytes, and sh-DDX3Y attenuated HG-induced injury. WTAP promoted DDX3Y mRNA stability via m6A methylation, exacerbating podocyte dysfunction. In diabetic mice, WTAP modulated DDX3Y to induce renal insufficiency and histopathological damage. Collectively, WTAP regulates DDX3Y via m6A methylation to promote HG-induced podocyte injury and DN progression.
Insights
Wilms' tumor 1-associating protein (WTAP) promotes diabetic nephropathy (DN) by stabilizing DDX3Y mRNA through N6-methyladenosine (m6A) modification, leading to podocyte injury and kidney damage.
Area of Science:
- Epigenetics
- Molecular Biology
- Nephrology
Background:
- Diabetic nephropathy (DN) is a severe diabetes complication with significant health and economic impacts.
- N6-methyladenosine (m6A) modification is a key epigenetic regulator affecting cellular functions and disease development.
- Wilms' tumor 1-associating protein (WTAP) is a crucial component of the m6A methyltransferase complex.
Purpose of the Study:
- To investigate the role of WTAP in diabetic nephropathy (DN).
- To elucidate the molecular mechanism by which WTAP influences DN progression.
- To explore the potential of targeting the WTAP/DDX3Y axis in DN treatment.
Main Methods:
- Bioinformatic analysis of differentially expressed genes in DN.
- Establishment of a high glucose (HG)-induced podocyte model in vitro.
- Western blot, CCK-8, ELISA, flow cytometry, and TUNEL assays for cellular analysis.
- MeRIP and xenograft models for validating m6A modification and in vivo effects.
Main Results:
- WTAP and DDX3Y expression were elevated in DN conditions and HG-induced podocytes.
- Knockdown of DDX3Y (sh-DDX3Y) alleviated HG-induced podocyte injury.
- WTAP enhanced DDX3Y mRNA stability through m6A methylation, worsening podocyte dysfunction.
- WTAP/DDX3Y modulation in diabetic mice led to renal insufficiency and histopathological damage.
Conclusions:
- WTAP promotes podocyte injury and DN progression via m6A-mediated regulation of DDX3Y stability.
- The WTAP/DDX3Y pathway represents a potential therapeutic target for diabetic nephropathy.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Specific Gene Expression
Canonical Wnt Signaling Pathway